These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6751436

  • 21. Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.
    Bladé J, San Miguel JF, Alcalá A, Maldonado J, Sanz MA, García-Conde J, Moro MJ, Alonso C, Besalduch J, Zubizarreta A.
    J Clin Oncol; 1993 Jun; 11(6):1165-71. PubMed ID: 8501503
    [Abstract] [Full Text] [Related]

  • 22. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
    Snigurowicz J, Kraj M, Rostkowska J, Maj S, Mariańska B, Mendek E, Roszkowski S, Kilian Z, Kołakowski L.
    Arch Immunol Ther Exp (Warsz); 1981 Jun; 29(2):145-53. PubMed ID: 7030265
    [No Abstract] [Full Text] [Related]

  • 23. Phase III study of intermittent 5-drug regimen (VBCMP) versus intermittent 3-drug regimen (VMP) versus intermittent melphalan and prednisone (MP) in myelomatosis.
    Hansen OP, Clausen NA, Drivsholm A, Laursen B.
    Scand J Haematol; 1985 Nov; 35(5):518-24. PubMed ID: 3911373
    [Abstract] [Full Text] [Related]

  • 24. Chronic lymphocytic leukemia.
    Rai KR, Sawitsky A, Jagathambal K, Gartenhaus W, Phillips E.
    Med Clin North Am; 1984 May; 68(3):697-711. PubMed ID: 6379339
    [Abstract] [Full Text] [Related]

  • 25. Combination chemotherapy for multiple myeloma with BCNU, cyclophosphamide, vincristine, melphalan, and prednisone (M-2 protocol).
    Case DC, Sonneborn HL, Paul SD, Hayes DM, Dorsk BM, Carroll RJ, Bove L.
    Oncology; 1985 May; 42(3):137-40. PubMed ID: 3858763
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma.
    Gössinger H, Bettelheim P, Neumann E, Hinterberger W, Korninger K, Niessner H, Pabinger-Fasching I, Bauer K, Lechner K.
    Blut; 1984 Nov; 49(5):383-8. PubMed ID: 6548652
    [Abstract] [Full Text] [Related]

  • 27. [Results of the combined treatment of advanced multiple myeloma by the M-2 protocol: cyclophosphamide, vincristine, melphalan, nitrosourea and prednisone].
    Gola A, Niewolna M, Weryńska B.
    Pol Arch Med Wewn; 1987 May; 77(5):200-5. PubMed ID: 3078182
    [No Abstract] [Full Text] [Related]

  • 28. [Results with the use of the M-2 protocol in plasmacytoma].
    Ho AD, Wittkamp S, Theml H, Keilholz U, Hunstein W.
    Dtsch Med Wochenschr; 1986 May 30; 111(22):858-61. PubMed ID: 3754811
    [Abstract] [Full Text] [Related]

  • 29. Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.
    Kyle RA, Pajak TF, Henderson ES, Nawabi IU, Brunner K, Henry PH, McIntyre OR, Holland JF.
    Cancer Treat Rep; 1982 Mar 30; 66(3):451-6. PubMed ID: 7060034
    [Abstract] [Full Text] [Related]

  • 30. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA.
    Cancer Treat Rep; 1986 Aug 30; 70(8):953-8. PubMed ID: 3015406
    [Abstract] [Full Text] [Related]

  • 31. Combination chemotherapy study for remission maintenance in ALL: an evaluation of vincristine, cyclophosphamide and vincristine, cyclophosphamide, and BCNU: a Southwest Oncology Group Phase II Study.
    Sexauer CL, Vietti T, Humphrey GB.
    Am J Pediatr Hematol Oncol; 1981 Aug 30; 3(3):255-7. PubMed ID: 6945060
    [Abstract] [Full Text] [Related]

  • 32. Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
    Dreger P, von Neuhoff N, Kuse R, Sonnen R, Glass B, Uharek L, Schoch R, Löffler H, Schmitz N.
    Br J Cancer; 1998 Jun 30; 77(12):2291-7. PubMed ID: 9649148
    [Abstract] [Full Text] [Related]

  • 33. [Value of successive chemotherapy in multiple myeloma of bone. Prospective study over 4 years].
    Bataille R, Morlock G, Rosenberg F, Lopitaux R, Blotman F, Sany J, Ciurana AJ, Rampon S, Bussière JL, Simon L, Serre H.
    Rev Rhum Mal Osteoartic; 1980 Feb 30; 47(2):77-82. PubMed ID: 7361063
    [Abstract] [Full Text] [Related]

  • 34. [Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone].
    Montalbán C, Zapatero A, Blanco L, Sevilla F, García Laraña J, Odriozola J.
    Sangre (Barc); 1984 Feb 30; 29(6):993-9. PubMed ID: 6549486
    [No Abstract] [Full Text] [Related]

  • 35. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
    Johnson S, Smith AG, Löffler H, Osby E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W.
    Lancet; 1996 May 25; 347(9013):1432-8. PubMed ID: 8676625
    [Abstract] [Full Text] [Related]

  • 36. Relapse in childhood acute lymphoblastic leukemia after elective cessation of initial treatment: failure of subsequent treatment with cyclophosphamide, cytosine arabinoside, vincristine and prednisone (COAP).
    Sallan SE, Hitchcock-Bryan S.
    Med Pediatr Oncol; 1981 May 25; 9(5):455-62. PubMed ID: 6946278
    [Abstract] [Full Text] [Related]

  • 37. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
    Durant JR, Loeb V, Dorfman R, Chan YK.
    Cancer; 1975 Dec 25; 36(6):1936-44. PubMed ID: 1106833
    [Abstract] [Full Text] [Related]

  • 38. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Oncol; 1993 Oct 25; 20(5 Suppl 7):21-3. PubMed ID: 8235691
    [Abstract] [Full Text] [Related]

  • 39. [Present status of chemotherapy in ALL and CLL].
    Ogawa M.
    Gan To Kagaku Ryoho; 1982 Nov 25; 9(11):1882-7. PubMed ID: 6964032
    [Abstract] [Full Text] [Related]

  • 40. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B, Brugiatelli M, Krc I, Losonczi H, Holowiecki J, Planinc-Peraica A, Kusec R, Morabito F, Iacopino P, Lutz D.
    Cancer; 1997 Jun 01; 79(11):2107-14. PubMed ID: 9179056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.